Trading Statement

Oxford Instruments PLC
05 April 2007


5 April 2007 



                             Oxford Instruments Plc

                                 Trading Update



Oxford Instruments plc, the high technology tools and systems company, is today
providing an update on trading in advance of publishing its preliminary results
for the year ended 31 March 2007 on 13 June 2007.

Results for the year, before non-recurring items and amortisation of acquired
intangibles, are expected to be in line with market expectations.

In addition, the Company is in negotiations to exit the High Field NMR business.
While the outcome of these negotiations is still uncertain, an exit is likely to
lead to a one-off non-cash write off, which is not expected to exceed £3m.



Enquiries:


Oxford Instruments plc Tel: [phone]

Jonathan Flint Chief Executive

Kevin Boyd Group Finance Director


Hogarth Partnership Tel: [phone]

Rachel Hirst

Andrew Jaques


Notes to Editors


Oxford Instruments designs, supplies and supports high-technology tools,
processes and solutions with a focus on physical science, bioscience,
environmental and industrial research and applications. It provides solutions
needed to advance fundamental nanoscience research and its transfer into
commercial nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 40 years, and its
strategy is to effect the successful commercialisation of these ideas by
bringing them to market in a timely and customer-focused fashion.


The first technology business to be spun out from Oxford University over forty
years ago, Oxford Instruments is now a global company with over 1,300 staff
worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to
be the leading provider of new generation tools and systems for the Physical
Science and Bioscience sectors.


This involves the combination of core technologies in areas such as low
temperature and high magnetic field environments, Nuclear Magnetic Resonance,
X-ray electron and optical based metrology, and advanced growth, deposition and
etching. Our products, expertise, and ideas address global issues such as
energy, environment, terrorism and health and are part of the next generation of
telecommunications, energy products, environmental measures, security devices,
drug discovery and medical advances.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
                 BBQ